Emergent BioSolutions (EBS) files $100M Mixed Securities Shelf Registration
Emergent BioSolutions Inc. (NYSE: EBS) filed with the U.S. Securities and Exchange Commission (SEC) a universal shelf registration statement which, when declared effective, will permit the company to issue up to an aggregate of $100 million of common stock, preferred stock, debt securities and warrants.
Create E-mail AlertRelated Categories
Equity OfferingsStocks Mentioned
-0.37Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
